Seldom has a neuroscience finding so directly challenged assumptions about what the brain requires to fundamentally alter its own patterns of activity. A study published in November 2025 in Communications Biology examined twenty healthy adults before and after a seven-day residential retreat. The program, held in San Diego, combined guided meditation, lectures, and group practices. No substances were administered at any point during the intervention. Yet the neurological changes observed were remarkably analogous to those typically induced by psychedelic compounds.
The researchers employed functional magnetic resonance imaging to measure connectivity within the default mode network. This network comprises brain regions that become active during self-referential thought, daydreaming, and mental rumination. Following the retreat, connectivity within this network had diminished sharply and significantly. Participants also reported mystical or ego-dissolving experiences at levels the lead researcher deemed comparable to psilocybin. The brain had apparently reached this attenuated state on its own, without any pharmacological assistance.
What distinguishes this study from prior contemplative neuroscience research is the breadth of its biological measurements. Beyond neuroimaging, the investigators analysed whole plasma proteomics, metabolomics, and exosome-specific microRNA transcriptomics. They identified molecular changes in pathways associated with neuroplasticity, inflammation, and stress-related hormones. These converging lines of evidence suggest that an immersive retreat may reconfigure both neural and molecular processes simultaneously.
Nevertheless, the study's methodological constraints warrant careful scrutiny. It was observational in design, with no separate control group who spent a comparable week doing something else. Consequently, the researchers cannot disentangle the effects of meditation from those of isolation, routine, or digital abstinence. The sample size of twenty participants further limits the generalisability of these findings. The authors themselves characterise the work as exploratory rather than conclusive.
Despite these caveats, the implications are noteworthy for both clinical and theoretical neuroscience. The default mode network has been implicated in depression, anxiety, and excessive rumination. If sustained contemplative practice can attenuate its activity as profoundly as pharmacological agents, new therapeutic avenues may emerge. Further controlled trials will be indispensable in determining whether meditation alone can replicate these effects.
